Stock listing
OTC:RUBY Rubius Therapeutics Inc Stock
Follow Rubius Therapeutics Inc into a list and get an email when it puts out news.
Delisted OTC:RUBY no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- OTC:RUBY
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
Rubius Therapeutics Inc on 6ix
- Decks
- 3 decks · latest Mar 15, 2021
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (March 2021) | Technical | 39 slides | Mar 15, 2021 |
| Investor Presentation (January 2021) | Investor deck | 28 slides | Jan 11, 2021 |
| Investor Presentation (January 2020) | Investor deck | 33 slides | Jan 13, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Langer Other companies: Seer, Inc. (Director · Since at least Dec 3, 2020); Lyra Therapeutics, Inc. (David H. Koch Institute Professor, Massachusetts Institute of Technology · Since at least Apr 30, 2020); Korro Bio, Inc. (Director · Oct 2, 2019 – Aug 17, 2022 · Past); Moderna, Inc. (Director · Dec 7, 2018 – May 6, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 12, 2018 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 21, 2016 · Past); Ocata Therapeutics Inc (Director · Oct 4, 2011 – Feb 10, 2016 · Past) | Director · Jul 17, 2018 – Oct 14, 2019 · Past |
| Catherine Angell Sohn Other companies: Maze Therapeutics, Inc. (Director · Since at least Jan 30, 2025); Altimmune, Inc. (Director · Since at least Mar 23, 2023); Axcella Health Inc (Director · Aug 21, 2019 – May 19, 2022 · Past); Palisade Bio, Inc. (Director · Jan 13, 2014 – Jul 1, 2015 · Past); Lifecore Biomedical, Inc. (Director · Nov 13, 2012 – Jun 4, 2022 · Past); Jazz Pharmaceuticals plc (Director · Jul 27, 2012 – Aug 11, 2023 · Past) | Director · Jul 17, 2018 – May 12, 2022 · Past |
| Anne Prener Other companies: Keros Therapeutics, Inc. (Director · Since at least Jun 25, 2026); Damora Therapeutics, Inc. (Director · Since at least Jan 8, 2021); Kaleido Biosciences, Inc. (Director · Jun 30, 2021 – Jun 30, 2021 · Past) | Director · May 12, 2021 – May 12, 2022 · Past |
| Michael Rosenblatt Other companies: Axcella Health Inc (Director · May 19, 2022 – May 19, 2022 · Past); Azenta, Inc. (Director · Sep 4, 2018 – Feb 12, 2024 · Past); Merck & Company, Inc. (Exec V-P & Chief Med Officer · Dec 16, 2009 – May 10, 2016 · Past) | Director · Jul 17, 2018 – May 12, 2022 · Past |
| Susanne Schaffert Other companies: BioNTech SE (Member of the Board · Since at least Jun 26, 2026); Incyte Corporation (Director · Since at least Oct 1, 2022) | Director · Jul 12, 2022 – Jul 29, 2022 · Past |
| Jonathan Symonds Other companies: Innocoll AG (Director · Jan 1, 2017 – Jul 24, 2017 · Past) | Director · Jul 17, 2018 – May 12, 2022 · Past |
| Jose Carmona Other companies: ADC Therapeutics SA (Chief Financial Officer · Since at least Jan 2, 2024) | Chief Financial Officer · Oct 1, 2020 – Jan 31, 2022 · Past |
| Torben Straight Nissen Other companies: Axcella Health Inc (Director · Oct 10, 2022 – Nov 16, 2022 · Past) | President · Jul 17, 2018 – Jul 24, 2019 · Past |
| Christopher L Carpenter | Chief Medical Officer · Jul 17, 2018 – Dec 16, 2019 · Past |
| Laurence A Turka | Chief Scientific Officer · Jan 21, 2020 – Jan 29, 2023 · Past |
Log in to ask 6ix AI your own questions about Rubius Therapeutics Inc.